Ulcerative colitis. K51.0Ulcerative (chronic) pancolitisbackwash ileitis
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: The product of traditional medicine COLIT RELIF is presented in the form of a 250 mg capsule once a day along with food and also prednisolone st
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: For patients, the diagnosis of infectious colitis is caused by Clostridium deficiency colitis, ischemic colitis, and drug dependent colitis. Patients with moderate to severe ulcerative colitis were diagnosed in the last month of the REMISSION phase. Failure to use other complementary and alternative therapies Completion of consent form in an informed manner
Exclusion criteria
Exclusion criteria: Pregnancy or breastfeeding The creation of a drug complication or allergy Dissatisfaction with the continuation of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The results of this study could be used to propose a new treatment protocol for ulcerative colitis. Timepoint: Effect of traditional medicine coliT relife before intervention and in weeks 2, 4, 6, 8 and 10 after intervention. Method of measurement: Regular medical check-ups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proof of scientific validity and efficacy of traditional Iranian medicine in the treatment of ulcerative colitis. Timepoint: Before intervention and weeks 2, 4, and 6, 8 and 10 after intervention. Method of measurement: Regular patient visit and opinion form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Emtiazy
Yazd University of Medical Sciences
Outcome results
None listed